The paper presents the policy messages in 2 parts: consequences of nicotine consumption and actions to address nicotine-induced adverse health effects. HealthDay News — Nicotine is toxic to the heart ...
Pediatric patients aged 10 years and older with iron deficiency may now be treated with Accrufer following an expanded FDA approval.
Under a possible rule change outlined in a letter sent to supplement makers, the FDA would still require that warning on the package, but only once, rather than next to every health claim. HealthDay ...
The AAP represents about 67,000 pediatricians nationwide. The cuts come amid ongoing disagreements over vaccines.
Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).
The new legislations hope to amend the Higher Education Act of 1965 to restore the full loan limits that were narrowed under Trump’s so-called “Big Beautiful Bill." ...
The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...
Retatrutide treatment resulted in significant improvements in WOMAC pain scores and body weight compared with placebo in the TRIUMPH-4 trial.
Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback